- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for AtriCure Inc (ATRC)
| Open: | 9.0100 | Day's Range: | 8.9000 - 9.2400 | Volume: | 67,797 |
|---|---|---|---|---|---|
| Previous Close: | 9.0500 | 52wk Range: | 5.9000 - 9.9800 | 1-Yr Rtn: | +6.39% |
Key Statistics for ATRC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.4600 |
| Est. EPS (USD) (12/2013) | -0.4400 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 189.22 |
| Shares Outstanding (M) | 20.93 |
| 30 Day Average Volume | 66,299 |
| Price/Book (mrq) | 4.8679 |
| Price/Sale (ttm) | 2.1191 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ATRC
Company Profile & Key Executives for ATRC
AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company's bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation.
| Michael H Carrel "Mike"President/CEO | Douglas J Seith "Doug"Senior VP:Sales & Marketing |
| Andrew L LuxSenior VP:R&D And Ops & QA | M Andrew WadeVP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ATRC News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page